Skip to content

CannIbite

Active
Private limited company (pre-2019)founded 201412 yrs activeGroeningenlei 144, 2550 Kontich, BelgiumKBO/BCE: BE 0560.771.945
Summary

CannIbite has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €157,870 and a net result of €84,489. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 40% of 234 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

What they do
Research and development on biotechnology
NACE 72101NACE 72110
1 site
How big
€503,922total assets 2025
Equity
€157,870
Profit
€84,489
Turnover not published (abridged schema)
Financially healthy?
83 Excellent Checked score 2025
Bankruptcy chance 12 m
0.4%
Who decides
Accounts on time0 of 3 deeds read
Why 83- 1 change of registered office in 24 months- Liquidity: current ratio 8.36, cash €6,614+ Figures for FY 2025 (filed 31-07-2026)+ Sector Scientific research and development (NACE 72)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Better than 54% of its sector peers (NACE 72, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 56+16
equity 31.3% of total assets
Liquidity 51+44
short-term debt 11.7% · cash 1.3%
Profitability 79-21
return on assets 16.8%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (925 companies)
Last 3 months 08-2026: 0.4%highest value 09-2026: 0.4%▼ -0.9% vs 08-2026lowest value 10-2026: 0.4%● 0.0% vs 09-2026lowest value
  • 1 change of registered office in 24 months raises the probability
  • Figures for FY 2025 (filed 31-07-2026) lowers the probability
  • Liquidity: current ratio 8.36, cash €6,614 raises the probability
  • Sector Scientific research and development (NACE 72) lowers the probability
Credit up to €13,000 at 30 days acceptable
Liquidity ample (current ratio 8.36 against 1.19 in 2024; short-term debt: 11.7% and cash: 1.3% of total assets), but 68.7% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 72, micro). Better than this share of them on solvency 34%, liquidity 34%, profitability 56%, growth against the median 93%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · 1 change of registered office in 24 months
In the bankruptcy model this factor raises the probability.
Belgian State Gazette
lowers risk · Figures for FY 2025 (filed 31-07-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Liquidity: current ratio 8.36, cash €6,614
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Sector Scientific research and development (NACE 72)
In the bankruptcy model this factor lowers the probability.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
12 d late
2023
28 d late
2022
80 d late
2021
31 d late
2020
8 d early
2019
122 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 38 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 29 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Liquidity times 7current ratio 8.36
  3. Equity above €150,000Eq €157,870 ▲115%

Key points

  • Positive: Equity rose in 2025from €73,381 to €157,870 ▲ 115% View
  • Total assets 20256 fiscal years filed €503,922 View
  • Active since 2014founded 27-08-2014 12 years View

By topic

Financials

Fiscal year
2025
Total assets
€503,922
Profit
€84,489
Solvency
31.3%
Total assets▲ 0.1%
Net result
20182025
Go to Financials

Timeline

Events
17
Since
2017
Next accounts
by 31-07-2027
  1. 31-07-2026Annual accounts filed
  2. 31-12-2025Liquidity times 7
  3. 31-12-2025Equity above €150,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Research and development on biotechnologyNACE 72101
Founded
27-08-2014
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.